한글목차

세계 가치 기반 의료 시장은 2025년에 122억 2,000만 달러로 추정되며, 2032년에는 375억 7,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 17.4%의 성장률을 보일 것으로 예상됩니다.

그림. 가치 기반 의료 세계 시장 점유율(%), 지역별, 2025년

가치 기반 의료(Value Based Healthcare, VBHC)는 병원과 의사를 포함한 의료 제공자가 환자의 건강 결과에 따라 보상을 받는 의료 서비스 제공 모델입니다. 가치 기반 의료 계약에서 의료 제공자는 환자의 건강 증진을 도와 만성질환의 발병과 영향을 줄이고, 근거에 기반한 방식으로 건강한 삶을 살 수 있도록 돕는 것에 대한 보상을 받게 됩니다. 의료 서비스 제공자가 제공된 의료 서비스의 양에 따라 보상을 받는 Fee for Service에서 의료 제공자가 최저 비용으로 최고 품질의 의료를 제공하도록 인센티브를 받는 모델로 헬스케어 산업의 초점을 전환하는 것입니다. 이러한 전환을 위해서는 지불 모델과 의료 결과의 일관성이 필요하며, 의료 시스템과 의료 제공자는 이 새로운 목표를 달성하기 위해 운영, 재무 및 의료 제공 프로세스를 조정해야 합니다. 가 환자의 최선의 이익을 염두에 두고 설계되는 것을 중심으로 전개됩니다. 결과는 종종 치료의 질, 환자 만족도, 자원 활용의 효율성을 고려한 표준화된 도구로 측정되는 경우가 많습니다. VBHC의 도입은 의료 서비스 제공자가 의료 서비스 제공과 환자 관리에서 보다 효과적인 방법을 모색함으로써 혁신을 촉진하고, 의료 서비스 제공자가 보다 효과적인 방법을 모색하도록 유도하기 위한 것입니다. 또한, 모든 의료 활동이 환자에게 이익이 되는 측정 가능한 결과를 지향함으로써 보다 강력한 진료 조정과 통합적 진료 접근 방식을 촉진할 수 있습니다. 전 세계적으로 의료 시스템이 비용 상승과 환자 결과의 변동으로 어려움을 겪고 있는 가운데, VBHC는 건강 결과를 지속적으로 개선하고, 최적의 의료 서비스를 제공하고, 비용을 절감하는 데 있어 기본 축이 될 수 있습니다.

시장 역학:

세계 가치 기반 의료 시장을 촉진하는 주요 요인으로는 세계 의료비 증가, 고령 인구 증가, 집단건강관리 솔루션 도입 확대, 정부 정책 및 개혁 지원 등을 들 수 있습니다. 그러나 높은 인프라 및 구축 비용, 데이터 프라이버시 및 보안에 대한 우려, 상환 모델 변경에 대한 거부감 등은 시장 성장을 저해하는 요인으로 작용하고 있습니다.

본 조사의 주요 특징

• 세계의 가치 기반 의료(Value Based Healthcare) 시장을 상세히 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)을 조사 분석하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 가치 기반 의료 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 가치 기반 의료 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 가치 기반 의료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 서비스 요금에서 가치 기반 지불 모델로의 이동
• 정부 이니셔티브
• 첨단 기술의 도입
• 주요 하이라이트
• 규제 시나리오
• 최근 동향
• 제품 발매/승인
• PEST 분석
• PORTER의 분석
• 합병, 인수 및 제휴

제4장 세계의 가치 기반 의료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 가치 기반 의료 시장, 모델별, 2020-2032년

• 성과 보수
• 환자 중심 의료 홈
• 공유 저축
• 리스크 공유
• 일괄 지불
• 캐피테이션모델

제6장 세계의 가치 기반 의료 시장, 지불자별, 2020-2032년

• 메디케어와 메디케어 어드밴티지
• 메디케이드
• 상업

제7장 세계의 가치 기반 의료 시장, 제공자별, 2020-2032년

• 재택 헬스케어
• 시설 케어
• 셀프 케어
• 병원에서의 케어
• 입원
• 외래

제8장 세계의 가치 기반 의료 시장, 지역별, 2020-2032년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Baker Tilly US, LLP
  • Change Healthcare
  • Athena Healthcare
  • Curation Health
  • UnitedHealth Group
  • McKesson Corporation
  • Deloitte
  • Siemens Medical Solutions USA, Inc.
  • Signify Health, Inc.(Sentara Healthcare)
  • Humana
  • NXGN Management, LLC.

제10장 섹션

• 참고문헌
• 조사 방법
• 출판사 소개

영문목차

Global Value-Based Healthcare Market is estimated to be valued at USD 12.22 Bn in 2025 and is expected to reach USD 37.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032.

Figure. Global Value-Based Healthcare Market Share (%), By Region 2025

Value-based healthcare (VBHC) is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes. Under value-based care agreements, providers are rewarded for helping patients improve their health, thereby reduce the incidence and effects of chronic disease, and live healthier lives in an evidence-based way. At its core, VBHC shifts the healthcare industry's focus from fee-for-service, where providers are paid for the volume of care services delivered, to a model where providers are incentivized to deliver the highest quality of care at the lowest cost. This transition necessitates the alignment of payment models with health outcomes, which means healthcare systems and providers must adjust operational, financial, and care delivery processes to meet these new goals. The principles of VBHC revolve around patient-centered care, meaning, that all healthcare decisions and quality measurements are designed with the patient's best interest in mind. Outcomes are often measured through standardized tools that account for the quality of care, patient satisfaction, and efficiency of resource use. These outcomes are then used as a basis for compensating providers. The adoption of VBHC is meant to spur innovation, as providers seek more effective ways to deliver health services and manage patient care. It also encourages a stronger care coordination and integrated care approach, whereby all healthcare activities are geared towards measurable outcomes that benefit patients. As healthcare systems globally grapple with rising costs and variable patient outcomes, VBHC represents a fundamental pivot toward sustainably improving health outcomes, thus fostering optimal care delivery, and controlling costs.

Market Dynamics:

The key drivers propelling the global value-based healthcare market include rising healthcare expenditure worldwide, growing geriatric population, increasing adoption of population health management solutions, and supportive government policies & reforms. However, high infrastructural & deployment costs, data privacy & security concerns, and reluctance towards changing reimbursement models are some factors hindering the market growth.

Key features of the study:

• This report provides in-depth analysis of the global value-based healthcare market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global value-based healthcare market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Baker Tilly US, LLP, Change Healthcare, Athena Healthcare, Curation Health, UnitedHealth Group, McKesson Corporation, Deloitte, Siemens Medical Solutions USA, Inc., Signify Health, Inc. (Sentara Healthcare), Humana, and NXGN Management, LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global value-based healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global value-based healthcare market.

Detailed Segmentation:

• Global Value-Based Healthcare Market, By Models
  • Pay for Performance
  • Patient-centered Medical Home
  • Shared Savings
  • Shared Risk
  • Bundled Payment
  • Capitation Models
• Global Value-Based Healthcare Market, By Payer
  • Medicare and Medicare Advantage
  • Medicaid
  • Commercial
• Global Value-Based Healthcare Market, By Providers
  • Home Health Care
  • Frontloading Skilled Nursing Visits
  • Specialized Frontloading Therapy Visits
  • Institutional Care
  • Self-Care
  • Hospital Therapy
  • In-patient
  • Outpatient
• Global Value-Based Healthcare Market, By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Baker Tilly US, LLP
  • Change Healthcare
  • Athena Healthcare
  • Curation Health
  • UnitedHealth Group
  • McKesson Corporation
  • Deloitte
  • Siemens Medical Solutions USA, Inc.
  • Signify Health, Inc. (Sentara Healthcare)
  • Humana
  • NXGN Management, LLC.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Value-Based Healthcare Market, By Models
  • Market Value-Based Healthcare Market, By Payer
  • Market Value-Based Healthcare Market, By Providers
  • Market Value-Based Healthcare Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
• Shift from fee-for-service to value-based payment models
• Government initiatives
• Adoption of advanced technologies
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Value-Based Healthcare Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Value-Based Healthcare Market, By Models, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pay for Performance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Patient-centered Medical Home
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Shared Savings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Shared Risk
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Bundled Payment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Capitation Models
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Value-Based Healthcare Market, By Payer, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Medicare and Medicare Advantage
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Medicaid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Commercial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Value-Based Healthcare Market, By Providers, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Segment Trends
• Home Health Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Frontloading Skilled Nursing Visits
  • Specialized Frontloading Therapy Visits
• Institutional Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Self-Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Hospital Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• In-patient
• Outpatient

8. Global Value-Based Healthcare Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2020 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Models, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Providers, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Models, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Providers, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Models, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Providers, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Models, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Providers, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Models, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Providers, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Models, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Providers, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Company Profile
  • Baker Tilly US, LLP
• Company Highlights
• Models Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Change Healthcare
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Athena Healthcare
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Curation Health
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • UnitedHealth Group
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • McKesson Corporation
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Deloitte
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Siemens Medical Solutions USA, Inc.
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Signify Health, Inc. (Sentara Healthcare)
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Humana
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • NXGN Management, LLC.
• Company Highlights
• Models Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us